Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,523 signal articles · 29 in last 24h · 122,273 total before filter · latest 1h ago
29last 24h
1255last 7d
211● bullish (7d)
150● bearish (7d)
205publishers
AllMacro211Earnings431M&A97Regulatory23Product9Analyst11
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Does Cisco’s Expanded AI Infrastructure Orders and Employee Agents Change The Bull Case For Cisco Systems (CSCO)?
Simply Wall St.10d agoneutral
Does Cisco’s Expanded AI Infrastructure Orders and Employee Agents Change The Bull Case For Cisco Systems (CSCO)?

Cisco Systems recently briefed investors and industry audiences on its AI and networking ambitions through conference presentations in Taipei and Santa Clara, while preparing to release its fiscal Q4 2026 results after the market close on August 12. At the same time, Cisco has begun rolling out personalized AI agents to its roughly 90,000 employees and raised its full-year AI infrastructure order outlook, underscoring how deeply AI is being woven into both its operations and revenue...

Why Hewlett Packard Enterprise (HPE) Stock Is Trading Up Today
StockStory10d agoneutral
Why Hewlett Packard Enterprise (HPE) Stock Is Trading Up Today

Shares of enterprise technology company Hewlett Packard Enterprise (NYSE:HPE) jumped 3.9% in the morning session after Morgan Stanley upgraded the stock to Overweight from Equal Weight and set a $69 price target. The firm said it had been “on the wrong side” of the enterprise hardware trade and now sees a stronger setup for HPE’s server business. Morgan Stanley’s shift rests on pricing and order strength. Hardware refresh cycles, customers pulling spending forward, and AI-related demand are supp

Johnson & Johnson (JNJ) Advances Seltorexant And Expands Outpatient Cardiac Care
Simply Wall St.10d agoneutral
Johnson & Johnson (JNJ) Advances Seltorexant And Expands Outpatient Cardiac Care

Johnson & Johnson (NYSE: JNJ) is advancing its novel antidepressant Seltorexant into late stage clinical development for major depressive disorder as a potential rapid acting treatment option. The company also entered a multi year partnership with ACCESS to expand adoption of advanced cardiac electrophysiology technologies in ambulatory surgery centers. Both moves align with Johnson & Johnson’s focus on higher growth therapeutic and medtech areas that are important for its long term...

Samsung Electronics (KOSE:A005930) Stock Looks Cheap Even After A 304% Run
Simply Wall St.10d agoneutral
Samsung Electronics (KOSE:A005930) Stock Looks Cheap Even After A 304% Run

Samsung Electronics stock has posted very strong gains over the last three years, yet its current valuation checks still point to the shares looking inexpensive on several measures. With the price recently at ₩256,000, the question for investors is how much of the story is already reflected in that move. Samsung Electronics has returned about 304% over the last three years, which puts a lot more weight on whether today’s price still leaves room for a reasonable margin of safety. The launch...

Trimble Q2 Earnings Call Highlights
MarketBeat10d agoneutral
Trimble Q2 Earnings Call Highlights

Trimble (NASDAQ:TRMB) reported second-quarter results that exceeded its guidance midpoint, driven by strength in its architecture, engineering, construction and operations business and Field Systems segment. The company also raised its full-year outlook, authorized a new $1 billion share repurchase

Big Cash, Bigger Ambitions: POET Technologies Eyes 147% Upside
24/7 Wall St.10d agoneutral
Big Cash, Bigger Ambitions: POET Technologies Eyes 147% Upside

POET Technologies carries a fortress balance sheet, a landmark customer contract, and a Malaysia production ramp finally moving toward real shipments, yet lawsuits, massive dilution, and a sky-high valuation make this one of the most polarizing AI photonics bets on the Nasdaq right now.

National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter
Exec Edge10d agoneutral
National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter

By Karen Roman National Vision Holdings, Inc. (Nasdaq: EYE) said second quarter net revenue increased 2.5% to $498.8 million compared to the year prior and net income was $12.4 million against $8.7 million, with net income margin up to 2.5% from 1.8%. Diluted earnings per share were $0.15 compared to $0.11, and adjusted operating income […] The post National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter appeared first on ExecEdge.